Paycom Software, Inc. Reports Second Quarter 2022 Results
Paycom Software reported strong performance in Q2 2022, with total revenues reaching $317 million, a 31% increase year-over-year. GAAP net income was $57 million, or $0.99 per diluted share, while non-GAAP net income was $73 million or $1.26 per diluted share. Adjusted EBITDA stood at $120 million, representing 38% of total revenues. Recurring revenues accounted for 98.3% of total revenues. The company expects Q3 2022 revenues between $327 million and $329 million and full-year revenues of $1.354 billion to $1.356 billion.
- Total revenues increased 31% year-over-year to $317 million.
- GAAP net income rose to $57 million, a $5 million increase from last year.
- Non-GAAP net income increased by over 29% to $73 million.
- Adjusted EBITDA increased significantly to $120 million, or 38% of total revenues.
- Recurring revenues made up 98.3% of total revenues.
- None.
Second Quarter Revenues of
Second Quarter GAAP Net Income of
Second Quarter Non-GAAP Net Income of
Second Quarter Adjusted EBITDA of
“Our very strong second quarter results further illustrate the quality of the fundamentals of our business and the strong demand for our solutions,” said Paycom’s founder and CEO,
Financial Highlights for the Second Quarter of 2022
Total Revenues of
GAAP Net Income was
Non-GAAP Net Income1 was
Adjusted EBITDA1 was
Cash and Cash Equivalents were
Total Debt, Net was
1 Adjusted EBITDA and non-GAAP net income are non-GAAP financial measures. Please see the discussion below under the heading "Use of Non-GAAP Financial Information" and the reconciliations at the end of this release for additional information concerning these and other non-GAAP financial measures.
Financial Outlook
Paycom provides the following expected financial guidance for the quarter ending
Quarter Ending
Total Revenues in the range of
Adjusted EBITDA in the range of
Year Ending
Total Revenues in the range of
Adjusted EBITDA in the range of
We have not reconciled the forward-looking adjusted EBITDA ranges presented above and discussed on the teleconference call to net income, nor the forward-looking adjusted EBITDA margins discussed on the teleconference call to net income margin, because applicable information for future periods, on which these reconciliations would be based, is not readily available due to uncertainty regarding, and the potential variability of, depreciation and amortization, interest expense, taxes, non-cash stock-based compensation expense, change in fair value of our interest rate swap and other items. Further, we have not reconciled the forward-looking adjusted gross margin range discussed on the teleconference call to GAAP gross margin because applicable information for future periods, on which this reconciliation would be based, is not readily available due to uncertainty regarding, and the potential variability of, cost of revenues, including non-cash stock-based compensation expense. Accordingly, reconciliations of the forward-looking adjusted EBITDA ranges to net income, the forward-looking adjusted EBITDA margins to net income margin and the forward-looking adjusted gross margin range to gross margin are not available at this time without unreasonable effort. During the teleconference call, we also refer to a forward-looking estimate of our implied revenue growth rate plus adjusted EBITDA margin, or the “Rule of 65.” Because we are unable to reconcile forward-looking adjusted EBITDA margin to net income margin without unreasonable effort, we are unable to reconcile the “Rule of 65” to a comparable GAAP measure without unreasonable effort.
Use of Non-GAAP Financial Information
To supplement our financial information presented in accordance with generally accepted accounting principles in
The non-GAAP financial measures presented in this press release and discussed on the related teleconference call are not measures of financial performance under GAAP and should not be considered a substitute for net income, gross profit, gross margin, research and development expenses, sales and marketing expenses, administrative expenses and total research and development costs. Non-GAAP financial measures have limitations as analytical tools, and when assessing our operating performance, you should not consider these non-GAAP financial measures in isolation, or as a substitute for the consolidated statements of income data prepared in accordance with GAAP. The non-GAAP financial measures that we present may not be comparable to similarly titled measures of other companies and other companies may not calculate such measures in the same manner as we do.
Conference Call Details:
In conjunction with this announcement, Paycom will host a conference call today,
About Paycom
As a leader in payroll and HR technology,
Forward-Looking Statements
Certain statements in this press release are, and certain statements on the related teleconference call may be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are any statements that refer to Paycom’s estimated or anticipated results, other non-historical facts or future events and include, but are not limited to, statements regarding our business strategy; anticipated future operating results and operating expenses, cash flows, capital resources, dividends and liquidity; trends, opportunities and risks affecting our business, industry and financial results; future expansion or growth plans and potential for future growth; our ability to attract new clients to purchase our solution; our ability to retain clients and induce them to purchase additional applications; our ability to accurately forecast future revenues and appropriately plan our expenses; market acceptance of our solution and applications; our expectations regarding future revenues generated by certain applications; our ability to attract and retain qualified employees and key personnel; future regulatory, judicial and legislative changes; how certain factors affecting our performance correlate to improvement or deterioration in the labor market; our plan to open additional sales offices and our ability to effectively execute such plan; the sufficiency of our existing cash and cash equivalents to meet our working capital and capital expenditure needs over the next 12 months; our plans regarding our capital expenditures and investment activity as our business grows, including with respect to research and development and the expansion of our corporate headquarters and other facilities; the expected impact on our consolidated financial statements of new accounting pronouncements; our plans to repurchase shares of our common stock through a stock repurchase plan; our expected income tax rate for future periods; and the impact of the novel coronavirus (COVID-19) pandemic on our business, results of operations, cash flows, financial condition and liquidity. In addition, forward-looking statements also consist of statements involving trend analyses and statements including such words as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “should,” “will,” “would,” and similar expressions or the negative of such terms or other comparable terminology. These forward-looking statements speak only as of the date hereof and are subject to business and economic risks. As such, our actual results could differ materially from those set forth in the forward-looking statements as a result of the factors discussed in our filings with the
|
|
|||||||
Unaudited Consolidated Balance Sheets |
|
|||||||
(in thousands, except per share amounts) |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
279,039 |
|
|
$ |
277,978 |
|
Accounts receivable |
|
|
20,078 |
|
|
|
9,490 |
|
Prepaid expenses |
|
|
37,779 |
|
|
|
23,729 |
|
Inventory |
|
|
1,647 |
|
|
|
1,131 |
|
Income tax receivable |
|
|
220 |
|
|
|
16,413 |
|
Deferred contract costs |
|
|
86,048 |
|
|
|
76,724 |
|
Current assets before funds held for clients |
|
|
424,811 |
|
|
|
405,465 |
|
Funds held for clients |
|
|
3,423,181 |
|
|
|
1,846,573 |
|
Total current assets |
|
|
3,847,992 |
|
|
|
2,252,038 |
|
Property and equipment, net |
|
|
374,940 |
|
|
|
348,953 |
|
Intangible assets, net |
|
|
55,969 |
|
|
|
58,028 |
|
|
|
|
51,889 |
|
|
|
51,889 |
|
Long-term deferred contract costs |
|
|
511,957 |
|
|
|
461,852 |
|
Other assets |
|
|
48,956 |
|
|
|
42,385 |
|
Total assets |
|
$ |
4,891,703 |
|
|
$ |
3,215,145 |
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
13,475 |
|
|
$ |
5,772 |
|
Accrued commissions and bonuses |
|
|
14,798 |
|
|
|
22,357 |
|
Accrued payroll and vacation |
|
|
41,802 |
|
|
|
34,259 |
|
Deferred revenue |
|
|
17,920 |
|
|
|
16,277 |
|
Current portion of long-term debt |
|
|
— |
|
|
|
1,775 |
|
Accrued expenses and other current liabilities |
|
|
54,904 |
|
|
|
63,397 |
|
Current liabilities before client funds obligation |
|
|
142,899 |
|
|
|
143,837 |
|
Client funds obligation |
|
|
3,425,573 |
|
|
|
1,846,573 |
|
Total current liabilities |
|
|
3,568,472 |
|
|
|
1,990,410 |
|
Deferred income tax liabilities, net |
|
|
135,282 |
|
|
|
145,504 |
|
Long-term deferred revenue |
|
|
90,960 |
|
|
|
85,149 |
|
Net long-term debt, less current portion |
|
|
29,000 |
|
|
|
27,380 |
|
Other long-term liabilities |
|
|
73,850 |
|
|
|
72,988 |
|
Total long-term liabilities |
|
|
329,092 |
|
|
|
331,021 |
|
Total liabilities |
|
|
3,897,564 |
|
|
|
2,321,431 |
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
|
|
|
Common stock, |
|
|
625 |
|
|
|
623 |
|
Additional paid-in capital |
|
|
517,777 |
|
|
|
465,594 |
|
Retained earnings |
|
|
1,064,864 |
|
|
|
915,579 |
|
Accumulated other comprehensive earnings (loss) |
|
|
(1,600 |
) |
|
|
— |
|
|
|
|
(587,527 |
) |
|
|
(488,082 |
) |
Total stockholders’ equity |
|
|
994,139 |
|
|
|
893,714 |
|
Total liabilities and stockholders’ equity |
|
$ |
4,891,703 |
|
|
$ |
3,215,145 |
|
|
|
|||||||||||||||
Unaudited Consolidated Statements of Comprehensive Income |
|
|||||||||||||||
(in thousands, except per share amounts) |
|
|||||||||||||||
|
|
|
|
|
|
|||||||||||
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
2022 |
|
|
|
2021 |
|
||
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recurring |
|
$ |
311,534 |
|
|
$ |
237,585 |
|
|
$ |
659,698 |
|
|
$ |
505,359 |
|
Implementation and other |
|
|
5,390 |
|
|
|
4,561 |
|
|
|
10,745 |
|
|
|
8,985 |
|
Total revenues |
|
|
316,924 |
|
|
|
242,146 |
|
|
|
670,443 |
|
|
|
514,344 |
|
Cost of revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses |
|
|
39,604 |
|
|
|
28,773 |
|
|
|
78,096 |
|
|
|
57,846 |
|
Depreciation and amortization |
|
|
10,478 |
|
|
|
7,637 |
|
|
|
20,470 |
|
|
|
14,837 |
|
Total cost of revenues |
|
|
50,082 |
|
|
|
36,410 |
|
|
|
98,566 |
|
|
|
72,683 |
|
Administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
|
87,724 |
|
|
|
67,979 |
|
|
|
162,720 |
|
|
|
130,740 |
|
Research and development |
|
|
36,803 |
|
|
|
28,224 |
|
|
|
68,408 |
|
|
|
52,935 |
|
General and administrative |
|
|
57,912 |
|
|
|
54,063 |
|
|
|
118,416 |
|
|
|
100,254 |
|
Depreciation and amortization |
|
|
12,090 |
|
|
|
8,380 |
|
|
|
23,753 |
|
|
|
16,096 |
|
Total administrative expenses |
|
|
194,529 |
|
|
|
158,646 |
|
|
|
373,297 |
|
|
|
300,025 |
|
Total operating expenses |
|
|
244,611 |
|
|
|
195,056 |
|
|
|
471,863 |
|
|
|
372,708 |
|
Operating income |
|
|
72,313 |
|
|
|
47,090 |
|
|
|
198,580 |
|
|
|
141,636 |
|
Interest expense |
|
|
(354 |
) |
|
|
— |
|
|
|
(569 |
) |
|
|
— |
|
Other income (expense), net |
|
|
878 |
|
|
|
146 |
|
|
|
2,290 |
|
|
|
775 |
|
Income before income taxes |
|
|
72,837 |
|
|
|
47,236 |
|
|
|
200,301 |
|
|
|
142,411 |
|
Provision for income taxes |
|
|
15,482 |
|
|
|
(5,042 |
) |
|
|
51,016 |
|
|
|
25,517 |
|
Net income |
|
$ |
57,355 |
|
|
$ |
52,278 |
|
|
$ |
149,285 |
|
|
$ |
116,894 |
|
Earnings per share, basic |
|
$ |
0.99 |
|
|
$ |
0.90 |
|
|
$ |
2.57 |
|
|
$ |
2.02 |
|
Earnings per share, diluted |
|
$ |
0.99 |
|
|
$ |
0.90 |
|
|
$ |
2.57 |
|
|
$ |
2.01 |
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
57,969 |
|
|
|
57,853 |
|
|
|
57,992 |
|
|
|
57,797 |
|
Diluted |
|
|
58,067 |
|
|
|
58,092 |
|
|
|
58,186 |
|
|
|
58,135 |
|
Comprehensive earnings (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
57,355 |
|
|
$ |
52,278 |
|
|
$ |
149,285 |
|
|
$ |
116,894 |
|
Unrealized net gains (losses) on available-for-sale securities |
|
|
(654 |
) |
|
|
— |
|
|
|
(2,176 |
) |
|
|
— |
|
Tax effect |
|
|
173 |
|
|
|
— |
|
|
|
576 |
|
|
|
— |
|
Other comprehensive income (loss), net of tax |
|
|
(481 |
) |
|
|
— |
|
|
|
(1,600 |
) |
|
|
— |
|
Comprehensive earnings (loss) |
|
$ |
56,874 |
|
|
$ |
52,278 |
|
|
$ |
147,685 |
|
|
$ |
116,894 |
|
|
|
|||||||
Unaudited Consolidated Statements of Cash Flows |
|
|||||||
(in thousands) |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|||||
|
|
2022 |
|
|
2021 |
|
||
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Net income |
|
$ |
149,285 |
|
|
$ |
116,894 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
44,223 |
|
|
|
30,933 |
|
Accretion of discount on available-for-sale securities |
|
|
(637 |
) |
|
|
(183 |
) |
Non-cash marketing expense |
|
|
876 |
|
|
|
157 |
|
Loss on disposition of property and equipment |
|
|
— |
|
|
|
132 |
|
Amortization of debt issuance costs |
|
|
167 |
|
|
|
18 |
|
Stock-based compensation expense |
|
|
46,323 |
|
|
|
47,373 |
|
Cash paid for derivative settlement |
|
|
(300 |
) |
|
|
(418 |
) |
Gain on derivative |
|
|
(1,368 |
) |
|
|
(287 |
) |
Deferred income taxes, net |
|
|
(9,646 |
) |
|
|
6,485 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(10,588 |
) |
|
|
(10,775 |
) |
Prepaid expenses |
|
|
(14,050 |
) |
|
|
(14,430 |
) |
Inventory |
|
|
(1,166 |
) |
|
|
80 |
|
Other assets |
|
|
(5,308 |
) |
|
|
1,631 |
|
Deferred contract costs |
|
|
(57,746 |
) |
|
|
(44,893 |
) |
Accounts payable |
|
|
7,655 |
|
|
|
2,267 |
|
Income taxes, net |
|
|
16,193 |
|
|
|
2,450 |
|
Accrued commissions and bonuses |
|
|
(7,559 |
) |
|
|
(3,785 |
) |
Accrued payroll and vacation |
|
|
7,543 |
|
|
|
4,111 |
|
Deferred revenue |
|
|
7,454 |
|
|
|
5,632 |
|
Accrued expenses and other current liabilities |
|
|
(2,393 |
) |
|
|
3,051 |
|
Net cash provided by operating activities |
|
|
168,958 |
|
|
|
146,443 |
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
Purchases of investments from funds held for clients |
|
|
(233,789 |
) |
|
|
(142,051 |
) |
Proceeds from investments from funds held for clients |
|
|
279,000 |
|
|
|
155,000 |
|
Purchases of property and equipment |
|
|
(67,721 |
) |
|
|
(62,732 |
) |
Net cash used in investing activities |
|
|
(22,510 |
) |
|
|
(49,783 |
) |
Cash flows from financing activities |
|
|
|
|
|
|
|
|
Proceeds from issuance of debt |
|
|
29,000 |
|
|
|
— |
|
Repurchases of common stock |
|
|
(94,652 |
) |
|
|
— |
|
Withholding taxes paid related to net share settlements |
|
|
(4,793 |
) |
|
|
(32,355 |
) |
Payments on long-term debt |
|
|
(29,287 |
) |
|
|
(888 |
) |
Net change in client funds obligation |
|
|
1,579,000 |
|
|
|
411,878 |
|
Payment of debt issuance costs |
|
|
(1,297 |
) |
|
|
— |
|
Net cash provided by financing activities |
|
|
1,477,971 |
|
|
|
378,635 |
|
Increase in cash, cash equivalents, restricted cash and restricted cash equivalents |
|
|
1,624,419 |
|
|
|
475,295 |
|
Cash, cash equivalents, restricted cash and restricted cash equivalents |
|
|
|
|
|
|
|
|
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period |
|
|
1,812,691 |
|
|
|
1,585,275 |
|
Cash, cash equivalents, restricted cash and restricted cash equivalents, end of period |
|
$ |
3,437,110 |
|
|
$ |
2,060,570 |
|
|
|
|||||||
Unaudited Consolidated Statements of Cash Flows |
|
|||||||
(in thousands) |
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|||||
|
|
2022 |
|
|
2021 |
|
||
Reconciliation of cash, cash equivalents, restricted cash and restricted cash equivalents |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
279,039 |
|
|
$ |
202,362 |
|
Restricted cash included in funds held for clients |
|
|
3,158,071 |
|
|
|
1,858,208 |
|
Total cash, cash equivalents, restricted cash and restricted cash equivalents, end of period |
|
$ |
3,437,110 |
|
|
$ |
2,060,570 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow information: |
|
|
|
|
|
|
|
|
Non-cash investing and financing activities: |
|
|
|
|
|
|
|
|
Purchases of property and equipment, accrued but not paid |
|
$ |
3,831 |
|
|
$ |
7,131 |
|
Stock-based compensation for capitalized software |
|
$ |
4,180 |
|
|
$ |
3,351 |
|
Right of use assets obtained in exchange for operating lease liabilities |
|
$ |
7,940 |
|
|
$ |
1,572 |
|
Unaudited Reconciliations of GAAP to Non-GAAP Financial Measures (in thousands, except per share amounts) |
||||||||||||||||
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Net income to adjusted EBITDA: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
57,355 |
|
|
$ |
52,278 |
|
|
$ |
149,285 |
|
|
$ |
116,894 |
|
Interest expense |
|
|
354 |
|
|
|
— |
|
|
|
569 |
|
|
|
— |
|
Provision for income taxes |
|
|
15,482 |
|
|
|
(5,042 |
) |
|
|
51,016 |
|
|
|
25,517 |
|
Depreciation and amortization |
|
|
22,568 |
|
|
|
16,017 |
|
|
|
44,223 |
|
|
|
30,933 |
|
EBITDA |
|
|
95,759 |
|
|
|
63,253 |
|
|
|
245,093 |
|
|
|
173,344 |
|
Non-cash stock-based compensation expense |
|
|
24,268 |
|
|
|
23,792 |
|
|
|
46,323 |
|
|
|
47,373 |
|
Change in fair value of interest rate swap |
|
|
(405 |
) |
|
|
(49 |
) |
|
|
(1,668 |
) |
|
|
(705 |
) |
Adjusted EBITDA |
|
$ |
119,622 |
|
|
$ |
86,996 |
|
|
$ |
289,748 |
|
|
$ |
220,012 |
|
Net income margin |
|
|
18.1 |
% |
|
|
21.6 |
% |
|
|
22.3 |
% |
|
|
22.7 |
% |
Adjusted EBITDA margin |
|
|
37.7 |
% |
|
|
35.9 |
% |
|
|
43.2 |
% |
|
|
42.8 |
% |
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Net income to non-GAAP net income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
57,355 |
|
|
$ |
52,278 |
|
|
$ |
149,285 |
|
|
$ |
116,894 |
|
Non-cash stock-based compensation expense |
|
|
24,268 |
|
|
|
23,792 |
|
|
|
46,323 |
|
|
|
47,373 |
|
Change in fair value of interest rate swap |
|
|
(405 |
) |
|
|
(49 |
) |
|
|
(1,668 |
) |
|
|
(705 |
) |
Income tax effect on non-GAAP adjustments |
|
|
(8,224 |
) |
|
|
(19,539 |
) |
|
|
(10,298 |
) |
|
|
(21,172 |
) |
Non-GAAP net income |
|
$ |
72,994 |
|
|
$ |
56,482 |
|
|
$ |
183,642 |
|
|
$ |
142,390 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
57,969 |
|
|
|
57,853 |
|
|
|
57,992 |
|
|
|
57,797 |
|
Diluted |
|
|
58,067 |
|
|
|
58,092 |
|
|
|
58,186 |
|
|
|
58,135 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share, basic |
|
$ |
0.99 |
|
|
$ |
0.90 |
|
|
$ |
2.57 |
|
|
$ |
2.02 |
|
Earnings per share, diluted |
|
$ |
0.99 |
|
|
$ |
0.90 |
|
|
$ |
2.57 |
|
|
$ |
2.01 |
|
Non-GAAP net income per share, basic |
|
$ |
1.26 |
|
|
$ |
0.98 |
|
|
$ |
3.17 |
|
|
$ |
2.46 |
|
Non-GAAP net income per share, diluted |
|
$ |
1.26 |
|
|
$ |
0.97 |
|
|
$ |
3.16 |
|
|
$ |
2.45 |
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Earnings per share to non-GAAP net income per share, basic: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share, basic |
|
$ |
0.99 |
|
|
$ |
0.90 |
|
|
$ |
2.57 |
|
|
$ |
2.02 |
|
Non-cash stock-based compensation expense |
|
|
0.42 |
|
|
|
0.41 |
|
|
|
0.80 |
|
|
|
0.82 |
|
Change in fair value of interest rate swap |
|
|
(0.01 |
) |
|
|
— |
|
|
|
(0.03 |
) |
|
|
(0.01 |
) |
Income tax effect on non-GAAP adjustments |
|
|
(0.14 |
) |
|
|
(0.33 |
) |
|
|
(0.17 |
) |
|
|
(0.37 |
) |
Non-GAAP net income per share, basic |
|
$ |
1.26 |
|
|
$ |
0.98 |
|
|
$ |
3.17 |
|
|
$ |
2.46 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Earnings per share to non-GAAP net income per share, diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share, diluted |
|
$ |
0.99 |
|
|
$ |
0.90 |
|
|
$ |
2.57 |
|
|
$ |
2.01 |
|
Non-cash stock-based compensation expense |
|
|
0.42 |
|
|
|
0.41 |
|
|
|
0.80 |
|
|
|
0.81 |
|
Change in fair value of interest rate swap |
|
|
(0.01 |
) |
|
|
— |
|
|
|
(0.03 |
) |
|
|
(0.01 |
) |
Income tax effect on non-GAAP adjustments |
|
|
(0.14 |
) |
|
|
(0.34 |
) |
|
|
(0.18 |
) |
|
|
(0.36 |
) |
Non-GAAP net income per share, diluted |
|
$ |
1.26 |
|
|
$ |
0.97 |
|
|
$ |
3.16 |
|
|
$ |
2.45 |
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Adjusted gross profit: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
316,924 |
|
|
$ |
242,146 |
|
|
$ |
670,443 |
|
|
$ |
514,344 |
|
Less: Total cost of revenues |
|
|
(50,082 |
) |
|
|
(36,410 |
) |
|
|
(98,566 |
) |
|
|
(72,683 |
) |
Total gross profit |
|
|
266,842 |
|
|
|
205,736 |
|
|
|
571,877 |
|
|
|
441,661 |
|
Plus: Non-cash stock-based compensation expense |
|
|
1,347 |
|
|
|
1,130 |
|
|
|
2,329 |
|
|
|
2,125 |
|
Total adjusted gross profit |
|
$ |
268,189 |
|
|
$ |
206,866 |
|
|
$ |
574,206 |
|
|
$ |
443,786 |
|
Gross margin |
|
|
84.2 |
% |
|
|
85.0 |
% |
|
|
85.3 |
% |
|
|
85.9 |
% |
Adjusted gross margin |
|
|
84.6 |
% |
|
|
85.4 |
% |
|
|
85.6 |
% |
|
|
86.3 |
% |
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Adjusted sales and marketing expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing expenses |
|
$ |
87,724 |
|
|
$ |
67,979 |
|
|
$ |
162,720 |
|
|
$ |
130,740 |
|
Less: Non-cash stock-based compensation expense |
|
|
(5,029 |
) |
|
|
(3,639 |
) |
|
|
(7,906 |
) |
|
|
(7,150 |
) |
Adjusted sales and marketing expenses |
|
$ |
82,695 |
|
|
$ |
64,340 |
|
|
$ |
154,814 |
|
|
$ |
123,590 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
316,924 |
|
|
$ |
242,146 |
|
|
$ |
670,443 |
|
|
$ |
514,344 |
|
Sales and marketing expenses as a % of revenues |
|
|
27.7 |
% |
|
|
28.1 |
% |
|
|
24.3 |
% |
|
|
25.4 |
% |
Adjusted sales and marketing expenses as a % of revenues |
|
|
26.1 |
% |
|
|
26.6 |
% |
|
|
23.1 |
% |
|
|
24.0 |
% |
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Adjusted total administrative expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total administrative expenses |
|
$ |
194,529 |
|
|
$ |
158,646 |
|
|
$ |
373,297 |
|
|
$ |
300,025 |
|
Less: Non-cash stock-based compensation expense |
|
|
(22,921 |
) |
|
|
(22,662 |
) |
|
|
(43,994 |
) |
|
|
(45,248 |
) |
Adjusted total administrative expenses |
|
$ |
171,608 |
|
|
$ |
135,984 |
|
|
$ |
329,303 |
|
|
$ |
254,777 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
316,924 |
|
|
$ |
242,146 |
|
|
$ |
670,443 |
|
|
$ |
514,344 |
|
Total administrative expenses as a % of revenues |
|
|
61.4 |
% |
|
|
65.5 |
% |
|
|
55.7 |
% |
|
|
58.3 |
% |
Adjusted total administrative expenses as a % of revenues |
|
|
54.1 |
% |
|
|
56.2 |
% |
|
|
49.1 |
% |
|
|
49.5 |
% |
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Adjusted research and development expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development expenses |
|
$ |
36,803 |
|
|
$ |
28,224 |
|
|
$ |
68,408 |
|
|
$ |
52,935 |
|
Less: Non-cash stock-based compensation expense |
|
|
(2,857 |
) |
|
|
(2,000 |
) |
|
|
(5,076 |
) |
|
|
(3,567 |
) |
Adjusted research and development expenses |
|
$ |
33,946 |
|
|
$ |
26,224 |
|
|
$ |
63,332 |
|
|
$ |
49,368 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
316,924 |
|
|
$ |
242,146 |
|
|
$ |
670,443 |
|
|
$ |
514,344 |
|
Research and development expenses as a % of revenues |
|
|
11.6 |
% |
|
|
11.7 |
% |
|
|
10.2 |
% |
|
|
10.3 |
% |
Adjusted research and development expenses as a % of revenues |
|
|
10.7 |
% |
|
|
10.8 |
% |
|
|
9.4 |
% |
|
|
9.6 |
% |
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Total research and development costs: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capitalized research and development costs |
|
$ |
16,440 |
|
|
$ |
13,708 |
|
|
$ |
31,840 |
|
|
$ |
26,003 |
|
Research and development expenses |
|
|
36,803 |
|
|
|
28,224 |
|
|
|
68,408 |
|
|
|
52,935 |
|
Total research and development costs |
|
$ |
53,243 |
|
|
$ |
41,932 |
|
|
$ |
100,248 |
|
|
$ |
78,938 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
316,924 |
|
|
$ |
242,146 |
|
|
$ |
670,443 |
|
|
$ |
514,344 |
|
Total research and development costs as a % of revenues |
|
|
16.8 |
% |
|
|
17.3 |
% |
|
|
15.0 |
% |
|
|
15.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted total research and development costs: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total research and development costs |
|
$ |
53,243 |
|
|
$ |
41,932 |
|
|
$ |
100,248 |
|
|
$ |
78,938 |
|
Less: Capitalized non-cash stock-based compensation |
|
|
(2,289 |
) |
|
|
(1,895 |
) |
|
|
(4,180 |
) |
|
|
(3,351 |
) |
Less: Non-cash stock-based compensation expense |
|
|
(2,857 |
) |
|
|
(2,000 |
) |
|
|
(5,076 |
) |
|
|
(3,567 |
) |
Adjusted total research and development costs |
|
$ |
48,097 |
|
|
$ |
38,037 |
|
|
$ |
90,992 |
|
|
$ |
72,020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
316,924 |
|
|
$ |
242,146 |
|
|
$ |
670,443 |
|
|
$ |
514,344 |
|
Adjusted total research and development costs as a % of revenues |
|
|
15.2 |
% |
|
|
15.7 |
% |
|
|
13.6 |
% |
|
|
14.0 |
% |
Unaudited Components of Non-Cash Stock-Based Compensation Expense (in thousands) |
||||||||||||||||
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Non-cash stock-based compensation expense: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses |
|
$ |
1,347 |
|
|
$ |
1,130 |
|
|
$ |
2,329 |
|
|
$ |
2,125 |
|
Sales and marketing |
|
|
5,029 |
|
|
|
3,639 |
|
|
|
7,906 |
|
|
|
7,150 |
|
Research and development |
|
|
2,857 |
|
|
|
2,000 |
|
|
|
5,076 |
|
|
|
3,567 |
|
General and administrative |
|
|
15,035 |
|
|
|
17,023 |
|
|
|
31,012 |
|
|
|
34,531 |
|
Total non-cash stock-based compensation expense |
|
$ |
24,268 |
|
|
$ |
23,792 |
|
|
$ |
46,323 |
|
|
$ |
47,373 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220802005163/en/
Investor Relations Contact:
investors@paycom.com
Source:
FAQ
What were Paycom's revenues for Q2 2022?
What is the GAAP net income for Paycom in Q2 2022?
What is the expected revenue range for Paycom in Q3 2022?
What was Paycom's adjusted EBITDA in Q2 2022?